Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population genetic testing for cancer susceptibility: founder mutations to genomes.

Nature reviews. Clinical oncology - 1 Jan 2016

Foulkes William D, Knoppers Bartha Maria, Turnbull Clare

Abstract excerpt

The current standard model for identifying carriers of high-risk mutations in cancer-susceptibility genes (CSGs) generally involves a process that is not amenable to population-based testing: access to genetic tests is typically regulated by health-care providers on the basis of a labour-intensive assessment of an individual's personal and family history of cancer, with face-to-face genetic counselling performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Founder Effect
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Genome, Human

Share to Mass Screening

Share to Ovarian Neoplasms

Share to Risk Assessment

Source

Identifiers

PMID: 26483301
DOI: 10.1038/nrclinonc.2015.173

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population genetic testing for cancer susceptibility: founder mutations to genomes.PMID 26483301Read ↗

Population‐based genetic testing for cancer susceptibility genes: quo vadis?Semantic proximity Read ↗

From the patient to the population: Use of genomics for population screeningSemantic proximity Read ↗

Genetic testing for cancer predisposition.Semantic proximity Read ↗

Population-based Genetic Testing for Precision Prevention.Semantic proximity Read ↗

Ethical and Psychosocial Issues Associated with Genetic Testing for Hereditary Tumor Predisposition SyndromesSemantic proximity Read ↗

Genetic testing for cancer risk.Semantic proximity Read ↗

Counselling framework for moderate-penetrance cancer-susceptibility mutations.Semantic proximity Read ↗

The Advantages and Challenges of Testing Children for Heritable Predisposition to Cancer.Semantic proximity Read ↗

Clinical implications of genomics for cancer risk genetics.Semantic proximity Read ↗

Genetic testing for cancer susceptibility: the promise and the pitfalls.Semantic proximity Read ↗

What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?Semantic proximity Read ↗

The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants—a multi-site prospective cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.